These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30129138)

  • 1. Elobixibat, an ileal bile acid transporter inhibitor, induces giant migrating contractions during natural defecation in conscious dogs.
    Taniguchi S; Yano T; Imaizumi M; Manabe N
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13448. PubMed ID: 30129138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulatory action of mitemcinal (GM-611), an acid-resistant non-peptide motilin receptor agonist, on colonic motor activity and defecation: spontaneous and mitemcinal-induced giant migrating contractions during defecation in dogs.
    Hirabayashi T; Morikawa Y; Matsufuji H; Hoshino K; Hagane K; Ozaki K
    Neurogastroenterol Motil; 2009 Oct; 21(10):1085-e91. PubMed ID: 19508333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study.
    Kamei D; Kamei Y; Nagano M; Mineshima M; Nitta K; Tsuchiya K
    BMC Gastroenterol; 2020 Jan; 20(1):26. PubMed ID: 32005162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
    Nakajima A; Seki M; Taniguchi S
    J Gastroenterol; 2018 Apr; 53(4):525-534. PubMed ID: 28840422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elobixibat for the treatment of constipation.
    Chedid V; Vijayvargiya P; Camilleri M
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):951-960. PubMed ID: 30204504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial.
    Kumagai Y; Amano H; Sasaki Y; Nakagawa C; Maeda M; Oikawa I; Furuie H
    Br J Clin Pharmacol; 2018 Oct; 84(10):2393-2404. PubMed ID: 29959787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological characteristics and clinical study results of ileal bile acid transporter inhibitor elobixibat (GOOFICE
    Ikeda N; Taniguchi S; Seki M
    Nihon Yakurigaku Zasshi; 2019; 153(3):129-138. PubMed ID: 30867382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota.
    Misawa N; Higurashi T; Takatsu T; Iwaki M; Kobayashi T; Yoshihara T; Ashikari K; Kessoku T; Fuyuki A; Matsuura T; Ohkubo H; Usuda H; Wada K; Naritaka N; Takei H; Nittono H; Matsumoto M; Honda A; Nakajima A; Camilleri M
    Aliment Pharmacol Ther; 2020 Sep; 52(5):821-828. PubMed ID: 32687674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation.
    Mosińska P; Fichna J; Storr M
    World J Gastroenterol; 2015 Jun; 21(24):7436-42. PubMed ID: 26139989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Calcitonin Gene-Related Peptide on Colonic Motility and Defecation in Conscious Dogs.
    Ono T; Nagao M; Imoto H; Watanabe K; Tanaka N; Motoi F; Naitoh T; Unno M
    J Gastrointest Surg; 2018 Dec; 22(12):2097-2103. PubMed ID: 29980973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation.
    Miner PB
    Expert Opin Pharmacother; 2018 Aug; 19(12):1381-1388. PubMed ID: 30129377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
    Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation.
    Nakajima A; Ishizaki S; Matsuda K; Kurosu S; Taniguchi S; Gillberg PG; Mattsson JP; Hasunuma T; Camilleri M
    J Gastroenterol Hepatol; 2022 May; 37(5):883-890. PubMed ID: 35168298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracolonic capsaicin stimulates colonic motility and defecation in conscious dogs.
    Hayashi K; Shibata C; Nagao M; Sato M; Kakyo M; Kinouchi M; Saijo F; Miura K; Ogawa H; Sasaki I
    Surgery; 2010 Jun; 147(6):789-97. PubMed ID: 20079916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracolonic Administration of the TRPA1 Agonist Allyl Isothiocyanate Stimulates Colonic Motility and Defecation in Conscious Dogs.
    Someya S; Nagao M; Shibata C; Tanaka N; Sasaki H; Kikuchi D; Miyachi T; Naitoh T; Unno M
    J Gastrointest Surg; 2015 Jul; 19(7):1342-9. PubMed ID: 25855335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant migrating contractions during defecation in the dog colon.
    Karaus M; Sarna SK
    Gastroenterology; 1987 Apr; 92(4):925-33. PubMed ID: 3556998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SC-435 on the gastrointestinal migrating myoelectric complex in guinea pigs.
    Zhang XM; Dong L; Liu LN; Lei YM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):497-503. PubMed ID: 16320575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice.
    Yamauchi R; Takedatsu H; Yokoyama K; Yamauchi E; Kawashima M; Nagata T; Uchida Y; Kitaguchi T; Higashi T; Fukuda H; Tsuchiya N; Takata K; Tanaka T; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Hepatol Int; 2021 Apr; 15(2):392-404. PubMed ID: 33398776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of physical exercise on colonic motor activity.
    Dapoigny M; Sarna SK
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G646-52. PubMed ID: 2018138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.